Marc Tessier-Lavigne

Marc Tessier-Lavigne is the founder of Renovis, Inc., founded in 2000.
Dr. Tessier-Lavigne was the founder of Denali Therapeutics, Inc., founded in 2013, and served as Independent Director from 2016 to 2026.
Dr. Tessier-Lavigne is also the founder of Xaira Therapeutics, Inc...
Dr. Tessier-Lavigne is Director at the Federal Reserve Bank of New York, Director at the Stanford Alumni Association, Director at the Bay Area Council Economic Institute, Director at The Rockefeller Archive Center, Member of The Royal Society, Member of the National Academy of Sciences, Member of the National Academy of Medicine (United States), Member of the American Philosophical Society, Member of the Royal Society of Canada, and Professor at Stanford University since 2023.
Dr. Tessier-Lavigne was Chairman at Agios Pharmaceuticals, Inc. from 2015 to 2016.
Dr. Tessier-Lavigne was Independent Director at Pfizer Inc. from 2012 to 2015.
Dr. Tessier-Lavigne was Independent Director at Regeneron Pharmaceuticals, Inc. from 2011 to 2023.
Dr. Tessier-Lavigne was Director at The Aaron Diamond AIDS Research Center.
Dr. Tessier-Lavigne was Independent Director at Juno Therapeutics, Inc. from 2014 to 2016.
Dr. Tessier-Lavigne was Chief Scientific Officer & Executive VP-Research at Genentech, Inc. from 2010 to 2011.
Dr. Tessier-Lavigne was Professor at The University of California, San Francisco from 1991 to 2001.
Dr. Tessier-Lavigne was President, Trustee & Professor at The Rockefeller University from 2013 to 2016.
Dr. Tessier-Lavigne was President at The Rockefeller University.
Dr. Tessier-Lavigne completed undergraduate degrees at McGill University in 1980 and at the University of Oxford in 1983.
Dr. Tessier-Lavigne earned a doctorate degree from University College London in 1987.